Press Releases October 2, 2026 08:30 AM

Phaos Technology Holdings (Cayman) Limited Announces One-For-Fifteen Reverse Stock Split

Phaos Technology announces one-for-fifteen reverse stock split to consolidate shares on NYSE American

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
POAS

Phaos Technology Holdings (Cayman) Limited, a Singapore-based advanced microscopy solutions company listed on the NYSE American as POAS, announced a one-for-fifteen reverse stock split approved by shareholders to consolidate issued Class A and Class B shares. The reverse split will not change shareholders' proportionate ownership and is expected to take effect on October 12, 2026.

Phaos Technology Holdings (Cayman) Limited Announces One-For-Fifteen Reverse Stock Split
POAS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • The reverse stock split consolidates every 15 existing shares into one share, increasing the par value per share accordingly.
  • The move will not affect the proportionate ownership of shareholders aside from minor rounding differences for fractional shares.
  • Phaos Technology specializes in AI-powered microscopy products serving manufacturing, biomedical, and research sectors.
  • Sectors impacted include advanced technology, manufacturing equipment, biomedical research, and AI-driven instrumentation markets.

SINGAPORE, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“Phaos” or “the Company”), an advanced microscopy solutions headquartered in Singapore, today announces Reverse Stock Split.

At the Company’s extraordinary general meeting of shareholders held on August 31, 2026, the Company’s shareholders approved a Reverse Stock Split of the Company’s issued and outstanding Class A ordinary shares and Class B ordinary shares at a ratio of one-for-fifteen (the “Reverse Stock Split”). As a result of the Reverse Stock Split, every fifteen (15) Class A ordinary shares of par value US$0.0001 each will be consolidated into one (1) Class A ordinary share of par value US$0.0015, and every fifteen (15) Class B ordinary shares of par value US$0.0001 each will be consolidated into one (1) Class B ordinary share of par value US$0.0015. No fractional shares will be issued in connection with the Reverse Stock Split; any fractional shares that would otherwise result will be rounded up to the nearest whole share. The Reverse Stock Split will not affect any shareholder’s proportionate ownership interest in the Company, except for minor changes arising from the rounding of fractional shares. The Reverse Stock Split is expected to become effective on October 12, 2026.

About Phaos Technology Holdings (Cayman) Limited
Phaos Technology Holdings (Cayman) Limited is an advanced microscopy technology company. Our commitment to innovation and excellence drives us to deliver state-of-the-art microscopy products and software solutions, powered by artificial intelligence, for diverse sectors including manufacturing, biomedical, and research. Experience the difference with Phaos Technology – where innovation meets sophistication, shaping the future of optical technology. For more information, please visit www.phaostech.com.

Forward Looking Statements
This news release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions that indicate future events or trends or are not statements of historical matters. These statements are based on our management’s current expectations and beliefs, as well as a number of assumptions concerning future events.

Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of our control and all of which could cause actual results to differ materially from the results discussed in the forward-looking statements. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements can be found in our reports filed with the United States Securities and Exchange Commission, which are available, free of charge, on the SEC’s website at www.sec.gov.

For more information please contact:

Company Contact:
Phaos Technology Holdings (Cayman) Limited
(65) 6250 3877
[email protected]


Risks

  • Post-split liquidity may be lower in the market due to reduced share count, potentially impacting trading in Phaos stock.
  • Reverse splits can sometimes be perceived negatively by investors as a method to meet minimum listing requirements, which could pressure the stock price.
  • Uncertainties in the company's ability to sustain growth and innovation in the competitive advanced microscopy and AI technology sectors may affect future performance.

More from Press Releases

Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026 Oct 2, 2026 Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group Oct 2, 2026 Hall Chadwick Acquisition Corp. and REEcycle Holdings, Inc. Announce Filing of Registration Statement on Form S-4 and Release Updated Investor Presentation Oct 2, 2026 Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting Oct 2, 2026 ATA Creativity Global Announces Receipt of a Bid Deficiency Notice from Nasdaq Oct 2, 2026